N-(4-(3-bromophenylamino)quinazolin-6-yl)acrylamide (Compound)

Description: A compound in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View N-(4-(3-bromophenylamino)quinazolin-6-yl)acrylamide's neighborhood in the knowledge graph.

Submit

Knowledge Graph Assertions

Source	Relation	Target	Evidence
N-(4-(3-bromophenylamino)quinazolin-6-yl)acrylamide Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	RBP1 Gene (Entity type)	-0.008105262
N-(4-(3-bromophenylamino)quinazolin-6-yl)acrylamide Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Epidermal growth factor receptor Protein (Entity type)	IC50
N-(4-(3-bromophenylamino)quinazolin-6-yl)acrylamide Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	CP Gene (Entity type)	0.00905607
N-(4-(3-bromophenylamino)quinazolin-6-yl)acrylamide Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	GPNMB Gene (Entity type)	0.009975718
N-(4-(3-bromophenylamino)quinazolin-6-yl)acrylamide Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	FABP5 Gene (Entity type)	-0.0081532225
N-(4-(3-bromophenylamino)quinazolin-6-yl)acrylamide Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	EIF5A Gene (Entity type)	-0.008042121
N-(4-(3-bromophenylamino)quinazolin-6-yl)acrylamide Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	FGA Gene (Entity type)	0.00885601
N-(4-(3-bromophenylamino)quinazolin-6-yl)acrylamide Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	PRKCH Gene (Entity type)	-0.008859684
N-(4-(3-bromophenylamino)quinazolin-6-yl)acrylamide Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	C1S Gene (Entity type)	0.008639245
N-(4-(3-bromophenylamino)quinazolin-6-yl)acrylamide Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	GOLT1B Gene (Entity type)	-0.00945221

N-(4-(3-bromophenylamino)quinazolin-6-yl)acrylamide
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
RBP1
Gene (Entity type)
-0.008105262

N-(4-(3-bromophenylamino)quinazolin-6-yl)acrylamide
Compound (Entity type)
Bioactivity
Knowledge Graph Relation (Entity type)
Epidermal growth factor receptor
Protein (Entity type)
IC50

N-(4-(3-bromophenylamino)quinazolin-6-yl)acrylamide
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
CP
Gene (Entity type)
0.00905607

N-(4-(3-bromophenylamino)quinazolin-6-yl)acrylamide
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
GPNMB
Gene (Entity type)
0.009975718

N-(4-(3-bromophenylamino)quinazolin-6-yl)acrylamide
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
FABP5
Gene (Entity type)
-0.0081532225

N-(4-(3-bromophenylamino)quinazolin-6-yl)acrylamide
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
EIF5A
Gene (Entity type)
-0.008042121

N-(4-(3-bromophenylamino)quinazolin-6-yl)acrylamide
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
FGA
Gene (Entity type)
0.00885601

N-(4-(3-bromophenylamino)quinazolin-6-yl)acrylamide
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
PRKCH
Gene (Entity type)
-0.008859684

N-(4-(3-bromophenylamino)quinazolin-6-yl)acrylamide
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
C1S
Gene (Entity type)
0.008639245

N-(4-(3-bromophenylamino)quinazolin-6-yl)acrylamide
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
GOLT1B
Gene (Entity type)
-0.00945221

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.